Published

A 100 mg vial contains extractable zolbetuximab 100 mg, arginine 116.2 mg, sucrose 256.48 mg, polysorbate 80 1.05 mg and phosphoric acid max 59.7 mg

The maximum extractable amount of phosphoric acid per 100 mg vial is estimated from historical batches at 59.7 mg/vial, corresponding to 3.8 mg/mL of phosphorous after reconstitution.1 

Table 1. Composition of zolbetuximab 100 mg viala,1

Component

Extractable amountb

Theoretical unit amountc

Zolbetuximab

100 mg

105 mgd

Arginine

116.2 mg

122 mg

Phosphoric acid

sufficient quantity to pH 6.0e

sufficient quantity to pH 6.0e

Sucrose

256.48 mg

269.3 mg

Polysorbate 80

1.05 mg

1.1 mg

a Nitrogen gas is used for backfilling and contained in the headspace of zolbetuximab vial.

b Extractable amount refers to the quantity that a trained healthcare professional should be able to retrieve from the reconstituted solution when following the recommended reconstitution and extraction procedures.

c Theoretical amount refers to the quantity of zolbetuximab and excipients added to the vial to enable extraction of 100 mg of zolbetuximab.

d Each vial contains an overfill of zolbetuximab relative to the nominal content (100 mg/vial) to ensure the deliverable dose is provided in each vial.

e The estimated maximum extractable amount of phosphoric acid per vial from the historical batches is 59.7 mg/vial, corresponding to 3.8 mg/mL of phosphorous after reconstitution. The upper limit for extractable amount of phosphoric acid per vial based on safety data is 67.9 mg/vial.

  1. Data on file. 

find-my-msl

Find My MSL

Medical Science Liaisons are available to help answer your scientific questions.

submit

Submit an Inquiry

For any medical inquiries, please submit your question online to Astellas Medical Information or call or fax your inquiry.

Astellas Phone: 1-800-727-7003

Fax: 1-877-829-7942

adverse

Report an Adverse Event or Product Complaint

Report adverse events and product complaints to Astellas or FDA MedWatch.

Astellas Phone: 1-800-727-7003

FDA MedWatch: 1-800-FDA-1088

Hours: M–F, 8 AM–4:30 PM (CT)